'Are you PM candidate?' Smriti Irani mocks Rahul Gandhi for Modi debate bid Rishabh Pant suspended: Sourav Ganguly tried blaming Rajasthan Royals, Sanju Samson; this is what BCCI said This Hybrid ...
AstraZeneca, which developed and manufactured the Covid vaccine Covishield. recently admitted that the vaccine could cause TTS (a condition that may cause blood clots and low platelet count) as a ...
“Roughly, the chances of TTS stood at 0.000003 per cent with Covishield in India, whereas globally, the risk stood at 0.0004 per cent," the government official told the news portal on condition ...
As panic spreads over Thrombosis Thrombocytopenia Syndrome, a blood clot side-effect being linked to the vaccine, doctors emphasise that the risk of heart attack and stroke is rare Listen to Story ...
AstraZeneca's COVISHIELD linked to rare TTS side effect, sparking global concern. India rolls out Covaxin alongside Covishield. Bharat Biotech assures Covaxin safety, efficacy, and thorough ...
Only seven to eight individuals out of 10 lakh, who receive the coronavirus vaccine Covishield, face the risk of experiencing a rare side effect known as thrombosis thrombocytopenia syndrome (TTS).
In India, almost 90% of people who received Covid vaccine, received the AstraZeneca vaccine which in India is called Covishield. Srishty Choudhury Updated : May 01, 2024, 10:57 AM IST Thrombosis ...
SII disclosed Covishield's rare side-effects in 2021, AstraZeneca withdrew global vaccine due to surplus, TTS. India halted manufacturing, faced mutant strains. Health experts note TTS involves ...
Serum Institute of India makes the AZ vaccine in India, and a response is awaited from it on the development. | Photo Credit: RAMAKRISHNA G As AstraZeneca faces a class action suit in the United ...
A group of doctors under the banner of Awaken India Movement (AIM) have raised concerns over the side effects of Covishield vaccine in the wake of pharmaceutical giant AstraZeneca admitting in a U ...
Dr. Raman Gangakhedkar, a leading epidemiologist and former ICMR scientist, stated that only a small fraction, about seven to eight individuals per one million, who receive the Covishield coronavirus ...